<?xml version="1.0" encoding="utf-8"?>
<urlset 
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
			<url>
				<loc>https://www.medicalnews.pk/10-Nov-2026/drap-safety-alert-heart-epilepsy-sleep-medicines-pakistan-webp</loc>					
				<news:news xmlns:n="http://www.google.com/schemas/sitemap-news/0.9">
					<news:publication>
						<news:name>Medical News Pakistan</news:name>
						<news:language>en</news:language>
					</news:publication>
					<news:publication_date>2026-11-10T21:00:00+05:00</news:publication_date>
					<news:title><![CDATA[DRAP issues safety alert over heart, epilepsy and sleep medicines in Pakistan]]></news:title>
										<news:keywords>DRAP Pakistan Drug Safety Alert Heart Medicines Epilepsy Medicines Sleep Disorders Flecainide Modafinil Mysoline Unregistered Drugs Patient Safety.'</news:keywords> 
									</news:news>
			</url>
					<url>
				<loc>https://www.medicalnews.pk/10-Nov-2026/fda-vision-loss-warnings-glp-1-drug-class</loc>					
				<news:news xmlns:n="http://www.google.com/schemas/sitemap-news/0.9">
					<news:publication>
						<news:name>Medical News Pakistan</news:name>
						<news:language>en</news:language>
					</news:publication>
					<news:publication_date>2026-11-10T18:16:00+05:00</news:publication_date>
					<news:title><![CDATA[FDA orders vision-loss warnings across GLP-1 drug class]]></news:title>
										<news:keywords>FDA Drug Safety, Ozempic, Wegovy, Mounjaro, Zepbound, GLP-1 Drugs, NAION.'</news:keywords> 
									</news:news>
			</url>
					<url>
				<loc>https://www.medicalnews.pk/10-Nov-2026/getz-pharma-second-who-prequalified-facility-export-prospects</loc>					
				<news:news xmlns:n="http://www.google.com/schemas/sitemap-news/0.9">
					<news:publication>
						<news:name>Medical News Pakistan</news:name>
						<news:language>en</news:language>
					</news:publication>
					<news:publication_date>2026-11-10T15:57:00+05:00</news:publication_date>
					<news:title><![CDATA[Getz Pharma's second WHO-prequalified facility boosts export prospects]]></news:title>
										<news:keywords>Getz Pharma, WHO Prequalification, Pakistan Pharmaceutical Exports, Moxifloxacin 400mg, Astola Manufacturing Facility, Tuberculosis Medicine, Pakistan Pharmaceutical Industry, WHO GMP.'</news:keywords> 
									</news:news>
			</url>
		</urlset>